{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:35:19Z","timestamp":1792157719133,"version":"4.4.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006475","name":"Bergens Forskningsstiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006475","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005029","name":"Helse Vest Regionalt Helsef\u00e0,retak","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2019.00463","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T07:19:46Z","timestamp":1558509586000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Quantitative PCR Measurement of miR-371a-3p and miR-372-p Is Influenced by Hemolysis"],"prefix":"10.3389","volume":"10","author":[{"given":"Mette Pernille","family":"Myklebust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikte","family":"Rosenlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peder","family":"Gjengst\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan Stefan","family":"Bercea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1sa","family":"Karlsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Bryd\u00f8y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/JCM.39.2.485-493.2001","article-title":"Purification and characterization of PCR-inhibitory components in blood cells.","volume":"39","author":"Al-Soud","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000477446","article-title":"Serum levels of MicroRNA371a-3p: a highly sensitive tool for diagnosing and staging testicular germ cell tumours: a clinical case series.","volume":"99","author":"Anheuser","year":"2017","journal-title":"Urol. Int."},{"key":"B3","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.eururo.2012.02.037","article-title":"Serum levels of microRNAs miR-371-3: a novel class of serum biomarkers for testicular germ cell tumors?","volume":"61","author":"Belge","year":"2012","journal-title":"Eur. Urol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ymeth.2012.09.015","article-title":"Assessing sample and miRNA profile quality in serum and plasma or other biofluids.","volume":"59","author":"Blondal","year":"2013","journal-title":"Methods"},{"key":"B5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01480","article-title":"Serum levels of MicroRNA-371a-3p (M371 Test) as a new biomarker of testicular germ cell tumors: results of a prospective multicentric study.","author":"Dieckmann","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"B7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eururo.2016.07.029","article-title":"Serum Levels of MicroRNA miR-371a-3p: a sensitive and specific new biomarker for germ cell tumours.","volume":"71","author":"Dieckmann","year":"2017","journal-title":"Eur. Urol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/bjc.2012.469","article-title":"MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.","volume":"107","author":"Dieckmann","year":"2012","journal-title":"Br. J. Cancer"},{"key":"B9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000444303","article-title":"MicroRNA miR-371a-3p - a novel serum biomarker of testicular germ cell tumors: evidence for specificity from measurements in testicular vein blood and in neoplastic hydrocele fluid.","volume":"97","author":"Dieckmann","year":"2016","journal-title":"Urol. Int."},{"key":"B10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1373\/clinchem.2013.211045","article-title":"Tolerance of droplet-digital PCR vs real-time quantitative PCR to inhibitory substances.","volume":"59","author":"Dingle","year":"2013","journal-title":"Clin. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.molonc.2013.08.002","article-title":"Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle.","volume":"7","author":"Gillis","year":"2013","journal-title":"Mol. Oncol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167969","article-title":"Stability of circulating blood-based MicroRNAs - pre-analytic methodological considerations.","volume":"12","author":"Glinge","year":"2017","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nmeth.2633","article-title":"Absolute quantification by droplet digital PCR versus analog real-time PCR.","volume":"10","author":"Hindson","year":"2013","journal-title":"Nat. Methods"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00094","article-title":"The impact of hemolysis on cell-free microRNA Biomarkers.","volume":"4","author":"Kirschner","year":"2013","journal-title":"Front. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1373\/clinchem.2015.251942","article-title":"Optimization and standardization of circulating microrna detection for clinical application: the miR-test case.","volume":"62","author":"Marzi","year":"2016","journal-title":"Clin. Chem."},{"key":"B16","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection.","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/bjc.2015.429","article-title":"A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.","volume":"114","author":"Murray","year":"2016","journal-title":"Br. J. Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1309\/AJCPOE11KEYZCJHT","article-title":"Identification of microRNAs From the miR-371\u223c373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors.","volume":"135","author":"Murray","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1158\/1055-9965.EPI-17-0657","article-title":"Future-proofing blood processing for measurement of circulating miRNAs in samples from biobanks and prospective clinical trials.","volume":"27","author":"Murray","year":"2018","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3892\/ol.2016.5452","article-title":"A methodological procedure for evaluating the impact of hemolysis on circulating microRNAs.","volume":"13","author":"Pizzamiglio","year":"2017","journal-title":"Oncol. Lett."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.288","article-title":"Evaluation of several methodological challenges in circulating miRNA qPCR studies in patients with head and neck cancer.","volume":"50","author":"Poel","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1159\/000488771","article-title":"The novel biomarker of germ cell tumours, micro-RNA-371a-3p, has a very rapid decay in patients with clinical stage 1.","volume":"100","author":"Radtke","year":"2018","journal-title":"Urol. Int."},{"key":"B23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method.","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153200","article-title":"Comparison of methodologies to detect low levels of hemolysis in serum for accurate assessment of serum microRNAs.","volume":"11","author":"Shah","year":"2016","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00216-018-0931-z","article-title":"Inhibition mechanisms of hemoglobin, immunoglobulin G, and whole blood in digital and real-time PCR.","volume":"410","author":"Sidstedt","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188085","article-title":"Steps to achieve quantitative measurements of microRNA using two step droplet digital PCR.","volume":"12","author":"Stein","year":"2017","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ydbio.2004.02.019","article-title":"Human embryonic stem cells express a unique set of microRNAs.","volume":"270","author":"Suh","year":"2004","journal-title":"Dev. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.juro.2014.07.010","article-title":"Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.","volume":"193","author":"Syring","year":"2015","journal-title":"J. Urol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103130","article-title":"MiR-371a-3p serum levels are increased in recurrence of testicular germ cell tumor patients.","volume":"19","author":"Terbuch","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s13402-017-0333-9","article-title":"microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.","volume":"40","author":"van Agthoven","year":"2017","journal-title":"Cell Oncol."},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2017.0338","article-title":"Germ cell tumour subtypes display differential expression of microRNA371a-3p.","volume":"373","author":"Vilela-Salgueiro","year":"2018","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.radonc.2014.11.006","article-title":"Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer.","volume":"113","author":"Xu","year":"2014","journal-title":"Radiother. Oncol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2019.00463\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T07:19:51Z","timestamp":1558509591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2019.00463\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":33,"alternative-id":["10.3389\/fgene.2019.00463"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2019.00463","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"article-number":"463"}}